Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence

• Published in: British journal of pharmacology Vol. 177; no. 6; pp. 1409 - 1423
• Main Authors: Lin, Shian‐Ren, Chang, Chia‐Hsiang, Hsu, Che‐Fang, Tsai, May‐Jwan, Cheng, Henrich, Leong, Max K., Sung, Ping‐Jyun, Chen, Jian‐Chyi, Weng, Ching‐Feng
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.03.2020; John Wiley and Sons Inc
• Subjects: Adjuvants; Cancer; Cancer therapies; Chemotherapy; Curcumin; Dietary Supplements; Functional foods & nutraceuticals; Herbs; Humans; Matairesinol; Neoplasms - drug therapy; Plant extracts; Resveratrol; Review; Side effects; Themed Section: Review; Toxicity
• ISSN: 0007-1188; 1476-5381; 1476-5381
• DOI: 10.1111/bph.14816

Traditional chemotherapy is being considered due to hindrances caused by systemic toxicity. Currently, the administration of multiple chemotherapeutic drugs with different biochemical/molecular targets, known as combination chemotherapy, has attained numerous benefits like efficacy enhancement and amelioration of adverse effects that has been broadly applied to various cancer types. Additionally, seeking natural‐based alternatives with less toxicity has become more important. Experimental evidence suggests that herbal extracts such as Solanum nigrum and Claviceps purpurea and isolated herbal compounds (e.g., curcumin, resveratrol, and matairesinol) combined with antitumoral drugs have the potential to attenuate resistance against cancer therapy and to exert chemoprotective actions. Plant products are not free of risks: Herb adverse effects, including herb–drug interactions, should be carefully considered. Linked Articles This article is part of a themed section on The Pharmacology of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.6/issuetoc